Henrik Vestergaard, acting chief executive of Lif, the Danish Industry Association, has taken aim at the USA’s ...

Swiss pharma giant Novartis revealed that it has entered into an agreement to acquire Avidity Biosciences, a San Diego, ...

Danish clinical-stage techbio, Evaxion has appointed Dr Helen Tayton-Martin as new chief executive (CEO). She will take up ...

Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for humanized anti-soluble aggregated amyloid-beta ...

Shares of BridgeBio Pharma rose more than 15% to $62.52 in early trading, after the company reported positive top-line ...

Privately-held Californian biopharma Sydnexis has announced that the US Food and Drug Administration (FDA) has issued a ...

UK biotech Levicept today reported key new data from its large-scale Phase II trial of LEVI-04 in a plenary presentation at ...

The US Food and Drug Administration (FDA) has approved German pharma major Bayer’s Lynkuet (elinzanetant) 60mg capsules, the ...

Sweden's climate for research and development is considered good by eight out of ten R&D managers in business, according to ...

Indian Torrent Pharma’s $3.1 billion merger with JB Chemicals has won approval from the regulator, the Competition Commission ...

The US Food and Drug Administration (FDA) has approved Revuforj (revumenib) for the treatment of relapsed or refractory (R/R) ...

Among last week’s significant news, US biotech Veridian Therapeutics announced it has entered into a royalty financing ...